Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07212231 · ClinicalTrials.gov registry record · NA
Radicle GI Health: A Study Assessing the Impact of Health and Wellness Products on Gastrointestinal (GI) Health and Related Health Outcomes.
A NA study, sponsored by Radicle Science.
- Completed
- Registry status
- NA
- Development phase
- 1,501
- Enrollment target
NCT07212231: Completed NA study, sponsored by Radicle Science.
NCT07212231 is a NA study that has completed, run by Radicle Science. The registered enrollment target is 1,501 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07212231, a NA study, has completed, sponsored by Radicle Science.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,501 participants
- Enrollment target
Study Summary
A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on GI Health and related health outcomes.
Primary Outcome
Difference between rates of change over time in lower GI collective score as assessed by a composite of PROMIS Gas and Bloating 13A , Constipation 9A, Diarrhea 6A, and Belly Pain 5A (scores 10-84; where the higher scores correspond to worse lower GI health)
Interventions
- DIETARY_SUPPLEMENT GI Product Placebo Control
- DIETARY_SUPPLEMENT Active Product 1
- DIETARY_SUPPLEMENT Active Product 2
- DIETARY_SUPPLEMENT Active Product 3
- DIETARY_SUPPLEMENT Active Product 4
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,501 participants |
| Start Date | 2025-10-16 |
| Est. Completion | 2026-03-02 |
| Phase | NA |
What the finished NCT07212231 record still lists
NCT07212231 is an interventional study that assigns participants to a tested intervention. Its 1,501 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 5 interventions - of which GI Product Placebo Control is the first listed.
NCT07212231 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07212231 about?
NCT07212231 is a clinical study titled "Radicle GI Health: A Study Assessing the Impact of Health and Wellness Products on Gastrointestinal (GI) Health and Related Health Outcomes.". A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on GI Health and related health outcomes.
What is the current status of trial NCT07212231?
This trial is currently completed. It is a NA study. The enrollment target is 1,501 participants. The study started on 2025-10-16. Estimated completion is 2026-03-02.
What interventions are being tested in trial NCT07212231?
The interventions under investigation include: GI Product Placebo Control (DIETARY_SUPPLEMENT), Active Product 1 (DIETARY_SUPPLEMENT), Active Product 2 (DIETARY_SUPPLEMENT), Active Product 3 (DIETARY_SUPPLEMENT), Active Product 4 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07212231?
This trial is sponsored by Radicle Science, which has 55 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07212231's enrollment target sits among peer trials
1,501 65th of 2000 higher than 1,936 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
- NCT01050504 · 1,500 participants
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
- NCT02071134 · 1,500 participants
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI